
Sign up to save your podcasts
Or


Get the breakdown for gastroenterology and rheumatology pharmacy practice with Dr. Alana Rice, who manages patients across multiple organ systems from her home office. Learn about the day-to-day reality of managing inflammatory bowel diseases and rheumatoid arthritis with biologics like Humira, Remicade, and newer biosimilars costing $10,000-$30,000 per dose. Alana explains the clinical complexity of TNF inhibitors, IL-12/23 inhibitors, and JAK inhibitors, plus how she monitors therapy response and inflammatory markers. She details her patient panel structure with 60-minute initial visits and 30-minute follow-ups, collaborative practice agreements that allow her to order labs and medications independently, and the insurance prior authorization process. Plus, discover alternative pathways into specialty practice beyond residency, the growing bioimilar market, and why BCACP certification gives you leverage across multiple ambulatory specialties.
π Key Takeaways from this Episode:
Quick Links:
π Subscribe to Newsletter For Exclusive Episode Recaps
π Become a Guest, fill out the form
π Make requests, submit questions, or give feedback
π About Pharmacy Pathways Video (3 min watch time)
Digging this content?
Disclaimers & Disclosures: The views and content expressed in this video are personal to the speaker(s) only, and not representative of any corresponding organizations or institutions. The content in this video (including text, graphics, images, and information) is intended for informational purposes, and may not be applicable to individual circumstances, therefore, speakers are not held accountable for the result of any actions taken or decisions made as a result of the content viewed. Always consult your healthcare provider for personalized medical advice.
By Dom The PharmacistGet the breakdown for gastroenterology and rheumatology pharmacy practice with Dr. Alana Rice, who manages patients across multiple organ systems from her home office. Learn about the day-to-day reality of managing inflammatory bowel diseases and rheumatoid arthritis with biologics like Humira, Remicade, and newer biosimilars costing $10,000-$30,000 per dose. Alana explains the clinical complexity of TNF inhibitors, IL-12/23 inhibitors, and JAK inhibitors, plus how she monitors therapy response and inflammatory markers. She details her patient panel structure with 60-minute initial visits and 30-minute follow-ups, collaborative practice agreements that allow her to order labs and medications independently, and the insurance prior authorization process. Plus, discover alternative pathways into specialty practice beyond residency, the growing bioimilar market, and why BCACP certification gives you leverage across multiple ambulatory specialties.
π Key Takeaways from this Episode:
Quick Links:
π Subscribe to Newsletter For Exclusive Episode Recaps
π Become a Guest, fill out the form
π Make requests, submit questions, or give feedback
π About Pharmacy Pathways Video (3 min watch time)
Digging this content?
Disclaimers & Disclosures: The views and content expressed in this video are personal to the speaker(s) only, and not representative of any corresponding organizations or institutions. The content in this video (including text, graphics, images, and information) is intended for informational purposes, and may not be applicable to individual circumstances, therefore, speakers are not held accountable for the result of any actions taken or decisions made as a result of the content viewed. Always consult your healthcare provider for personalized medical advice.